2023 annual financial data
Niki BioSolutions 2023 Operating margin
Direct answer
Operating margin was -2,457.47%.
Operating income was -10,601,000 USD and net income was -2,825,000 USD.
Operating cash flow was -7,724,364 USD.
Get free Niki BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 431,378 USD
- Operating income
- -10,601,000 USD
- Net income
- -2,825,000 USD
- Operating cash flow
- -7,724,364 USD